English   español  
Por favor, use este identificador para citar o enlazar a este item: http://hdl.handle.net/10261/25904
Compartir / Impacto:
Add this article to your Mendeley library MendeleyBASE
Citado 30 veces en Web of Knowledge®  |  Pub MebCentral Ver citas en PubMed Central  |  Ver citas en Google académico
Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL

Inhibiting the calcineurin-NFAT (nuclear factor of activated T cells) signaling pathway with a regulator of calcineurin-derived peptide without affecting general calcineurin phosphatase activity

AutorMulero, M. Carmen; Aubareda, Anna; Orzáez, Mar; Messeguer, Joaquim; Serrano-Candelas, Eva; Martínez-Hoyer, Sergio; Messeguer Peypoch, Ángel; Pérez-Payá, Enrique ; Pérez-Riba, Mercè
Fecha de publicación3-abr-2009
EditorAmerican Society for Biochemistry and Molecular Biology
CitaciónJournal of Biological Chemistry 284(14): 9394-9401 (2009)
ResumenCalcineurin phosphatase plays a crucial role in T cell activation. Dephosphorylation of the nuclear factors of activated T cells (NFATs) by calcineurin is essential for activating cytokine gene expression and, consequently, the immune response. Current immunosuppressive protocols are based mainly on calcineurin inhibitors, cyclosporine A and FK506. Unfortunately, these drugs are associated with severe side effects. Therefore, immunosuppressive agents with higher selectivity and lower toxicity must be identified. The immunosuppressive role of the family of proteins regulators of calcineurin (RCAN, formerly known as DSCR1) which regulate the calcineurin-NFAT signaling pathway, has been described recently. Here, we identify and characterize the minimal RCAN sequence responsible for the inhibition of calcineurin-NFAT signaling in vivo. The RCAN-derived peptide spanning this sequence binds to calcineurin with high affinity. This interaction is competed by a peptide spanning the NFAT PXIXIT sequence, which binds to calcineurin and facilitates NFAT dephosphorylation and activation. Interestingly, the RCAN-derived peptide does not inhibit general calcineurin phosphatase activity, which suggests that it may have a specific immunosuppressive effect on the calcineurin-NFAT signaling pathway. As such, the RCAN-derived peptide could either be considered a highly selective immunosuppressive compound by itself or be used as a new tool for identifying innovative immunosuppressive agents. We developed a low throughput assay, based on the RCAN1-calcineurin interaction, which identifies dipyridamole as an efficient in vivo inhibitor of the calcineurin-NFAT pathway that does not affect calcineurin phosphatase activity.
Descripción8 pages, 5 figures.-- PMID: 19189965 [PubMed].-- PMCID: PMC2666591.-- Supplementary information available at: http://www.jbc.org/content/suppl/2009/02/05/M805889200.DC1.html
Versión del editorhttp://dx.doi.org/10.1074/jbc.M805889200
ISSN0021-9258 (Print)
1083-351X (Online)
Aparece en las colecciones: (IQAC) Artículos
(IBV) Artículos
Ficheros en este ítem:
Fichero Descripción Tamaño Formato  
calcineurin_NFAT_Mulero.pdf663,6 kBAdobe PDFVista previa
Mostrar el registro completo

NOTA: Los ítems de Digital.CSIC están protegidos por copyright, con todos los derechos reservados, a menos que se indique lo contrario.